Literature DB >> 377292

Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

P Borgeat, B Samuelsson.   

Abstract

Addition of arachidonic acid and the divalent cation ionophore A23187 to a suspension of human peripheral blood polymorphonuclear leukocytes led to the formation of (5S)-hydroxy-6,8,11,14-icosatetraenoic acid, (15S)-hydroxy-5,8,11,13-icosatetraenoic acid, and (5S,12R)-dihydroxy-6,8,10,14-icosatetraenoic acid. A method based on high-pressure liquid chromatography has been developed for assay of these metabolites. The addition of arachidonic acid to human polymorphonuclear leukocytes always resulted in formation of the isomeric monohydroxy acids. However, cells prepared from blood of different subjects were found to vary with respect to formation of the 5,12-dihydroxy acid. Addition of the ionophore alone strongly stimulated the formation of the 5-monohydroxy acid and more specifically the 5,12-dihydroxy acid from endogenous arachidonic acid. In all experiments performed the formation of the 5-hydroxy acid and the 5,12-dihydroxy acid was maximally stimulated when both arachidonic acid and the ionophore were added to the incubation mixture. Under these conditions, stimulation of 40-fold or more of the formation of both compounds was observed. The data demonstrate that, in addition to causing release of endogenous substrate, the ionophore also activated the enzymatic system involved in the further transformations of arachidonic acid. This finding raises the possibility that this pathway of arachidonic acid metabolism is involved in the biological response (e.g., release of lysosomal enzymes, the slow reacting substance of anaphylaxis, and chemotactic factors) of leukocytes to A23187 and other stimuli.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377292      PMCID: PMC383554          DOI: 10.1073/pnas.76.5.2148

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  PROSTAGLANDINS AND RELATED FACTORS. 15. THE STRUCTURES OF PROSTAGLANDIN E1, F1-ALPHA, AND F1-BETA.

Authors:  S BERGSTROEM; R RYHAGE; B SAMUELSSON; J SJOEVALL
Journal:  J Biol Chem       Date:  1963-11       Impact factor: 5.157

2.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

3.  Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion.

Authors:  J I Gallin; J A Sandler; R I Clyman; V C Manganiello; M Vaughan
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Purification of guanylate cyclase from human platelets and effect of arachidonic acid peroxide.

Authors:  T Asano; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1977-10-10       Impact factor: 3.575

5.  Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides.

Authors:  H Hidaka; T Asano
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Calcium-dependent stimulation of thromboxane and prostaglandin biosynthesis by ionophores.

Authors:  O Oelz; H R Knapp; L J Roberts; R Oelz; B J Sweetman; J A Oates; P W Reed
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

Review 7.  Prostaglandins in inflammation.

Authors:  G P Lewis
Journal:  J Reticuloendothel Soc       Date:  1977-10

8.  Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium inophore A23187.

Authors:  B Wentzell; R M Epand
Journal:  FEBS Lett       Date:  1978-02-15       Impact factor: 4.124

9.  Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence.

Authors:  M J Weidemann; B A Peskar; K Wrogemann; E T Rietschel; H Staudinger; H Fischer
Journal:  FEBS Lett       Date:  1978-05-01       Impact factor: 4.124

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  166 in total

1.  Studies on the uptake, binding and metabolism of leukotriene B4 by human neutrophils.

Authors:  J Brom; W König
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

Review 2.  Transmembrane signaling, then and now: the decade of the eighties.

Authors:  J A Badwey
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  A neutrophil-derived cytochrome P450-dependent metabolite of arachidonic acid modulates neutrophil behavior.

Authors:  R Kraemer; M M Bednar; M A Hatala; K M Mullane
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

4.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.

Authors:  D M Aked; S J Foster
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

6.  Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit.

Authors:  A Sala; G Rossoni; C Buccellati; F Berti; G Folco; J Maclouf
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Mediators of arachidonic acid-induced contractions of indomethacin-treated guinea-pig airways: leukotrienes C4 and D4.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

8.  Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450.

Authors:  S Shak; I M Goldstein
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

9.  Oxidative inactivation of leukotriene C4 by stimulated human polymorphonuclear leukocytes.

Authors:  C W Lee; R A Lewis; E J Corey; A Barton; H Oh; A I Tauber; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

10.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.